Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 6/2021

04-02-2021

Frequency and influence of “not relevant” responses on the Dermatology Life Quality Index among adults with atopic dermatitis

Auteurs: John S. Barbieri, Zelma C. Chiesa Fuxench, Daniel B. Shin, Junko Takeshita

Gepubliceerd in: Quality of Life Research | Uitgave 6/2021

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

“Not relevant” responses (NRRs) on the Dermatology Life Quality Index (DLQI) are common among adults with psoriasis and may be associated with underestimation of disease burden. Little is known about “not relevant” responses among adults with atopic dermatitis. We aimed to examine the frequency of NRRs on the DLQI and to determine whether NRRs are associated with underestimation of disease burden among adults with atopic dermatitis.

Methods

Adults with atopic dermatitis were identified and evaluated via online survey. We evaluated the frequency of NRRs on the DLQI, stratified by sociodemographic characteristics. To examine the association between NRRs and other measures of disease burden, Patient-Oriented Eczema Measure (POEM), Patient-Oriented SCORAD (PO-SCORAD), and Short-Form (SF)-12 scores were compared between those who responded “not relevant” versus “not at all”.

Results

Among 764 adults with atopic dermatitis, most had mild disease. The median (interquartile range [IQR]) POEM, PO-SCORAD, and DLQI scores were 5 (2–10), 24 (14–34), and 2 (1–6), respectively. Most (55.2%) also had at least one NRR, and 17.9% had 4 or more “not relevant” responses, with differences across several sociodemographic characteristics. There were no substantial differences in SF-12, POEM, and PO-SCORAD scores between those who responded “not relevant” versus “not at all”.

Conclusion

NRRs on the DLQI are common among adults with atopic dermatitis and differ across sociodemographic characteristics, suggesting issues with content validity. There is not a clear association between NRRs and other measures of disease severity among adults with mostly mild atopic dermatitis.
vorige artikel Psycholinguistic features, design attributes, and respondent-reported cognition predict response time to patient-reported outcome measure items
volgende artikel Constructing arguments for the interpretation and use of patient-reported outcome measures in research: an application of modern validity theory
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
Finlay, A. Y., & Khan, G. K. (1994). Dermatology Life Quality Index (DLQI)—A simple practical measure for routine clinical use. Clinical and Experimental Dermatology, 19, 210–216.CrossRef
2.
Basra, M. K. A., Fenech, R., Gatt, R. M., Salek, M. S., & Finlay, A. Y. (2008). The Dermatology Life Quality Index 1994–2007: A comprehensive review of validation data and clinical results. British Journal of Dermatology, 159, 997–1035.
3.
Vincent, R., Chalmers, J. R., McWilliams, C., Thomas, K. S., Dodd, S., Rogers, N., et al. (2020). Assessing uptake of the Harmonising Outcome Measures for Eczema (HOME) Core outcome set and recommended instruments. British Journal of Dermatology, 183(3), 566–568.CrossRef
4.
Smith, C. H., Jabbar-Lopez, Z. K., Yiu, Z. Z., Bale, T., Burden, A. D., Coates, L. C., et al. (2017). British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017. British Journal of Dermatology, 177, 628–636.CrossRef
5.
Rencz, F., Gulácsi, L., Péntek, M., Szegedi, A., Remenyik, É., Bata-Csörgő, Z., et al. (2019). DLQI-R scoring improves the discriminatory power of Dermatology Life Quality Index in psoriasis, pemphigus and morphea patients. British Journal of Dermatology, 182(5), 1167–1175.CrossRef
6.
Rencz, F., Brodszky, V., Gulácsi, L., Péntek, M., Poór, A. K., Holló, P., et al. (2019). Time to revise the DLQI scoring in psoriasis treatment guidelines. Journal of the European Academy of Dermatology and Venereology, 33(7), e267–e269.CrossRef
7.
8.
Barbieri, J., & Gelfand, J. M. (2018). Evaluation of the Dermatology Life Quality Index scoring modification, the DLQI-R score, in two independent populations. British Journal of Dermatology, 180(4), 939–940.CrossRef
9.
Gupta, V., Taneja, N., Sati, H. C., Sreenivas, V., & Ramam, M. (2020). Evaluation of “not relevant” responses on the Dermatology Life Quality Index (DLQI) and the DLQI-R scoring modification among Indian patients with vitiligo. British Journal of Dermatology, 184(1), 168–169.CrossRef
10.
Barbieri, J. S., & Gelfand, J. M. (2019). Influence of “not relevant” responses on the Dermatology Life Quality Index (DLQI) for patients with psoriasis in the United States. JAMA Dermatology, 155, 743–745.CrossRef
11.
Barbieri, J. S., Shin, D. B., Syed, M. N., Takeshita, J., & Gelfand, J. M. (2020). Evaluation of the frequency of “not relevant” responses on the Dermatology Life Quality Index by sociodemographic characteristics of patients with psoriasis. JAMA Dermatology, 156(4), 446–450.CrossRef
12.
Rencz, F., Poór, A. K., Péntek, M., Holló, P., Kárpáti, S., Gulácsi, L., et al. (2018). A detailed analysis of “not relevant” responses on the DLQI in psoriasis: Potential biases in treatment decisions. Journal of the European Academy of Dermatology and Venereology, 32, 783–790.CrossRef
13.
Rencz, F., Gulácsi, L., Péntek, M., Poór, A. K., Sárdy, M., Holló, P., et al. (2018). Proposal of a new scoring formula for the DLQI in psoriasis. British Journal of Dermatology, 179(5), 1102–1108.CrossRef
14.
Nijsten, T. (2012). Dermatology life quality index: Time to move forward. Journal of Investigative Dermatology, 132, 11–13.CrossRef
15.
Chiesa Fuxench, Z. C., Block, J., Boguniewicz, M., Boyle, J., Fonacier, L., Gelfand, J. M., et al. (2018). Atopic Dermatitis in America Study: A cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population. Journal of Investigative Dermatology, 139(3), 583–590.CrossRef
16.
Williams, H. C., Burney, P. G., Pembroke, A. C., & Hay, R. J. (1996). Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. U.K. diagnostic criteria for atopic dermatitis working party. British Journal of Dermatology, 135, 12–7.CrossRef
17.
Naleway, A. L., Belongia, E. A., Greenlee, R. T., Kieke, B. A., Chen, R. T., & Shay, D. K. (2003). Eczematous skin disease and recall of past diagnoses: Implications for smallpox vaccination. Annals of Internal Medicine, 139, 1–7.CrossRef
18.
Hongbo, Y., Thomas, C. L., Harrison, M. A., Salek, M. S., & Finlay, A. Y. (2005). Translating the science of quality of life into practice: What do dermatology life quality index scores mean? Journal of Investigative Dermatology, 125, 659–664.CrossRef
19.
Charman, C. R., Venn, A. J., & Williams, H. C. (2004). The patient-oriented eczema measure: Development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective. Archives of Dermatology, 140, 1513–1519.CrossRef
20.
Spuls, P. I., Gerbens, L. A. A., Simpson, E., Apfelbacher, C. J., Chalmers, J. R., Thomas, K. S., et al. (2017). Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: A Harmonising Outcome Measures for Eczema (HOME) statement. British Journal of Dermatology, 176, 979–84.CrossRef
21.
Silverberg, J. I., Gelfand, J. M., Margolis, D. J., Fonacier, L., Boguniewicz, M., Schwartz, L. B., et al. (2018). Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis. Annals of Allergy, Asthma, & Immunology, 121(464–468), e3.
22.
Stalder, J.-F., Barbarot, S., Wollenberg, A., Holm, E. A., De Raeve, L., Seidenari, S., et al. (2011). Patient-Oriented SCORAD (PO-SCORAD): A new self-assessment scale in atopic dermatitis validated in Europe. Allergy, 66, 1114–1121.CrossRef
23.
Busija, L., Ackerman, I. N., Haas, R., Wallis, J., Nolte, S., Bentley, S., et al. (2020). Adult measures of general health and health-related quality of life. Arthritis Care & Research, 72(Suppl 10), 522–564.CrossRef
24.
Ware, J., Kosinski, M., & Keller, S. D. (1996). A 12-item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34, 220–233.CrossRef
25.
Jenkinson, C., Layte, R., Jenkinson, D., Lawrence, K., Petersen, S., Paice, C., et al. (1997). A shorter form health survey: Can the SF-12 replicate results from the SF-36 in longitudinal studies? Journal of Public Health and Medicine, 19, 179–186.CrossRef
26.
Gandek, B., Ware, J. E., Aaronson, N. K., Apolone, G., Bjorner, J. B., Brazier, J. E., et al. (1998). Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology, 51, 1171–8.CrossRef
27.
Hinkle, D., Wiersma, W., & Jurs, S. (2003). Applied statistics for the behavioral sciences (5th ed.). Boston: Houghton Mifflin.
28.
The GfK Group Project Report for the Atopic Dermatitis in America Study. GfK; 2017.
29.
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., et al. (2007). The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet (London, England), 370, 1453–1457.CrossRef
30.
He, Z., Lu, C., Basra, M. K. A., Ou, A., Yan, Y., & Li, L. (2013). Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis. Journal of the European Academy of Dermatology and Venereology, 27, 109–115.CrossRef
31.
Hahn, H. B., Melfi, C. A., Chuang, T. Y., Lewis, C. W., Gonin, R., Hanna, M. P., et al. (2001). Use of the Dermatology Life Quality Index (DLQI) in a midwestern US urban clinic. Journal of the American Academy of Dermatology, 45, 44–48.CrossRef
32.
Mazzotti, E., Barbaranelli, C., Picardi, A., Abeni, D., & Pasquini, P. (2005). Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis. Acta Dermato-Venereologica, 85, 409–413.CrossRef
33.
Terwee, C. B., Prinsen, C. A. C., Chiarotto, A., Westerman, M. J., Patrick, D. L., Alonso, J., et al. (2018). COSMIN methodology for evaluating the content validity of patient-reported outcome measures: A Delphi study. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 27, 1159–70.CrossRef
34.
Metagegevens
Titel
Frequency and influence of “not relevant” responses on the Dermatology Life Quality Index among adults with atopic dermatitis
Auteurs
John S. Barbieri
Zelma C. Chiesa Fuxench
Daniel B. Shin
Junko Takeshita
Publicatiedatum
04-02-2021
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 6/2021
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-021-02770-z

Andere artikelen Uitgave 6/2021

Quality of Life Research 6/2021 Naar de uitgave

OriginalPaper

Health-related quality of life and its predictors among adults living with HIV/AIDS and receiving antiretroviral therapy in Pakistan

OriginalPaper

COVID-19 pandemic reduces the negative perception of oral health-related quality of life in adolescents

Review

A closer look at quality of life in the hepatocellular carcinoma literature

OriginalPaper

Longitudinal change of quality of life in the first five years of survival among disease-free Chinese breast cancer survivors

OriginalPaper

Patient-reported outcomes and the identification of subgroups of atrial fibrillation patients: a retrospective cohort study of linked clinical registry and administrative data

OriginalPaper

Differences in mental health and health-related quality of life between the Israeli and Italian population during a COVID-19 quarantine